SMTL ID : 4d2s.1

Human TTK in complex with a Dyrk1B inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x DYK: N-{2-METHOXY-4-[(1-METHYLPIPERIDIN-4-YL)OXY]PHENYL}-4-(1H-PYRROLO[2,3-C]PYRIDIN-3-YL)PYRIMIDIN-2-AMINE(Non-covalent)

DYK.1: 17 residues within 4Å: Chain A: K.18, I.20, V.28, Q.30, A.40, K.42, I.75, M.91, E.92, C.93, G.94, N.95, I.96, D.97, S.100, L.143, I.152 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.28, A:V.28, A:I.75, A:L.143, A:I.152 Hydrogen bonds: A:G.94, A:G.94, A:S.100

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kettle, J.G. et al., Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors to Explore a Mek Resistance Hypothesis. J.Med.Chem. (2015)

Release Date

2015-04-22

Peptides

DUAL SPECIFICITY PROTEIN KINASE TTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

DUAL SPECIFICITY PROTEIN KINASE TTK